Your browser doesn't support javascript.
loading
Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.
Morán, Teresa; Felip, Eudald; Bosch-Barrera, Joaquim; de Aguirre, Itziar; Ramirez, Jose Luis; Mesia, Carles; Carcereny, Enric; Roa, Diana; Sais, Elia; García, Yolanda; Blanco, Remei; Sanchez, Silvia; Villacorta, Claudia Rosa; Queralt, Cristina; Velarde, Jose María; Rosell, Rafael.
Afiliación
  • Morán T; Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Felip E; Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Bosch-Barrera J; Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain.
  • de Aguirre I; Molecular Biology Laboratory of Cancer Dr. Rosell, Can Ruti Campus: Institute Germans Trias i Pujol (IGTP), Catalan Institute of Oncology, Badalona, Spain.
  • Ramirez JL; Molecular Biology Laboratory of Cancer Dr. Rosell, Can Ruti Campus: Institute Germans Trias i Pujol (IGTP), Catalan Institute of Oncology, Badalona, Spain.
  • Mesia C; Medical Oncology Department, Catalan Institute of Oncology - Hospital Duran i Reynalds, l'Hospitalet de Llobregat, Barcelona, Spain.
  • Carcereny E; Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Roa D; Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain.
  • Sais E; Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain.
  • García Y; Medical Oncology Department, Hospital Parc Taulí, Sabadell, Barcelona, Spain.
  • Blanco R; Medical Oncology Department, Consorci Sanitari de Terrassa, Terrassa, Barcelona, Spain.
  • Sanchez S; Research Nurse Team, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Villacorta CR; Research Nurse Team, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Queralt C; Molecular Biology Laboratory of Cancer Dr. Rosell, Can Ruti Campus: Institute Germans Trias i Pujol (IGTP), Catalan Institute of Oncology, Badalona, Spain.
  • Velarde JM; Statistics Department, Fundació Germans Trias i Pujol, Badalona, Spain.
  • Rosell R; Molecular Biology Laboratory of Cancer Dr. Rosell, Can Ruti Campus: Institute Germans Trias i Pujol (IGTP), Catalan Institute of Oncology, Badalona, Spain.
Oncotarget ; 10(26): 2576, 2019 04 02.
Article en En | MEDLINE | ID: mdl-31069018
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: España